# A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease

> **NCT06773962** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **TrueBinding, Inc.** · enrollment: 62 (estimated)

## Conditions studied

- Parkinson's Disease (PD)

## Interventions

- **DRUG:** TB006
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06773962
- **Lead sponsor:** TrueBinding, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-03-20
- **Primary completion:** 2026-11-28
- **Final completion:** 2026-11-28
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06773962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06773962, "A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06773962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*